A system has been designed to study the in vivo forward rate of mutation of human immunodeficiency virus type 1 (HIV-1) during one round of replication. A HIV-1 shuttle vector was used that contained the lacZa peptide gene as a reporter for mutations. The forward mutation rate of HIV-1 was found to be 3 1 10 05 mutations per target base pair per cycle, or about 20-fold lower than the error rates reported for purified HIV-1 reverse transcriptase with sense-strand RNA and DNA templates of the lacZa peptide gene in a cell-free system. To test the hypothesis that the vpr gene product might, at least in part, account for the lower mutation rate observed in vivo, a HIV-1 vector was replicated to determine if the mutation rate was higher in the absence of the wild-type vpr gene product. A vpr 0 shuttle vector had an overall mutation rate as much as 4-fold higher than that of the parental vector. A shuttle vector with an amino acid substitution in Vpr that prevents efficient incorporation of Vpr into virus particles was found to have a mutation frequency similar to that of the vpr 0 vector, and was interpreted to indicate a requirement for Vpr incorporation into the virus particle in order to observe the influence of vpr on the mutation rate. Replication of a vpr 0 shuttle vector in the presence of a wild-type vpr expression plasmid led to a mutation frequency similar to that of the parental vector, suggesting that the vpr mutation could be complemented in trans. Immunoprecipitation analysis indicated that Vpr virion incorporation coincided with the influence of vpr on the mutation rate. ᭧
INTRODUCTION
the average lifetime of an HIV-1-infected cell is less than 1 to 2 days (Ho et al., 1995; Wei et al., 1995) . The Retroviridae family of RNA viruses replicate A system has been developed to measure the forward through a DNA intermediate (Baltimore, 1970; Temin and mutation rate of HIV-1 with a vector containing the lacZa Mitzutani, 1970) . The viral RNA is copied into DNA by the peptide gene as a reporter for mutations (Mansky and viral-encoded enzyme reverse transcriptase in a process . This system allows for the study of mutaknown as reverse transcription. The process of reverse tions that occur during a single round of HIV-1 replication. transcription is known to be error-prone, contributing to
The mutation rate of HIV-1 in this system was determined the high genetic variability of retroviruses (Coffin, 1992;  to be 3 1 10 05 mutations per target base pair per cycle Holland et al., 1992; Katz and Skalka, 1990; Temin, 1961) .
in HeLa cells (Mansky and Temin, 1995) and 4 1 10
05
The error-prone nature of reverse transcription has been mutations per target base pair per cycle in a T-lymphoid proposed to be due to abnormal strand transfers that cell line (Mansky, 1996) . The most commonly detected can occur during this process . The level mutations were base substitution mutations (G to A and of genetic variation of human immunodeficiency virus C to T transition mutations) and frameshift mutations (01 type 1 (HIV-1) is high (Alizon et al., 1986; Balfe et al., frameshifts in runs of Ts and As). This mutation rate is 1990; Cheng-Mayer et al., 1991; Hahn et al., 1986; maximally 5% of the reported error rates for purified HIV-1993; Starcich et al., 1986; Wong-Staal, 1990) relative to 1 reverse transcriptase with a sense-strand RNA and some retroviruses in other genera (Dube et al., 1993;  DNA template in cell-free studies, indicating that the mu- Ratner et al., 1991; Willems et al., 1993) . Genetic variation tation rate of HIV-1 is less than that predicted by the of retroviruses can be viewed as the composite of several measured fidelity of purified HIV-1 reverse transcriptase variables: (1) the mutation rate per replication cycle, (2) (Boyer et al., 1992) . the number of replication cycles, (3) the fixation rate of
The difference between the in vivo mutation rate of mutations, and (4) the rate of recombination (Coffin, 1990;  HIV-1 and the error rate of purified HIV-1 reverse tran- Hu and Temin, 1990; Zhang and Temin, 1993) . It has scriptase may be due to several possibilities. One hybeen argued that HIV-1 completes about 300 or more pothesis is that, in vivo, protein factors and reverse trancycles per year (Coffin, 1995) , based on the reports that scriptase together contribute to the accuracy of reverse transcription; in the absence of these factors, the error rate of purified reverse transcriptase is higher. Protein vpr, tat, rev, vpu, and nef . Bent lines in between the coding regions for tat and rev show reading frames joined by splicing events. E indicates the location of the encapsidation signal. The simian virus 40 promoter (SV) is represented as a cross-hatched box, the neo gene is represented as a hatched rectangular box, the pACYC origin of replication is represented as the light gray box, and the lacZa peptide gene is represented as an open rectangular box with a black band representing the lac operator sequence. Dashed lines indicate deleted viral coding sequence removed by digestion with SwaI. The StuI and XhoI sites were used in the purification of the vector proviral DNA containing the neo gene, the pACYC origin of replication, and the lacZa peptide gene.
reverse transcriptase, to be present in virus particles. To made by a primary/combinatorial two-step polymerase test the hypothesis that viral proteins contribute to the chain reaction (PCR) protocol (Ito et al., 1991) . Oligonuaccuracy of reverse transcription, the HIV-1 vpr gene was cleotide primers that changed the start codon of the vpr mutated in order to determine the influence of vpr on the gene from ATG to ATT, but did not affect the overlapping rate of mutation. The vpr gene encodes a 96-amino-acid, vif open reading frame, were used as internal primers. nonstructural protein that is associated with virus partiThe PCR product from this reaction, containing the vpr cles and that requires the p6 region gene with the mutation of the start codon, was cloned of the gag gene for incorporation (Kondo et al., 1995; into the pCRII cloning vector (Invitrogen Corp., San Diego, et al., 1995 Paxton et al., 1993) . The incorporation CA). The cloned DNA was sequenced to verify the introof Vpr into virus particles implies a role either early in duced mutations using a nonradioactive DNA sequencthe HIV-1 replication cycle (prior to the synthesis of new ing kit (Silver Sequencing kit; Promega Corp., Madison, viral proteins) or late in the replication cycle (during as-WI) and digested with PflMI and SalI, and the fragment sembly and budding). Specific roles of vpr include the containing the vpr gene was cloned into the PflMI and nuclear localization of the preintegration complex and SalI sites of pHIV shuttle 3.12. prevention of cell proliferation during chronic infection
The construction of the Vpr virion-incorporation mutant (He et al., 1995; Heinzinger et al., 1994; Jowett et al., was made using a similar PCR mutagenesis protocol 1995; Planelles et al., 1995; Rogel et al., 1995) . This study used for pHIV shuttle 3.12 vprATG 0 (as described above). has found that the mutation rate of a vpr 0 vector mutant Nucleotide changes in the vpr gene of HIV shuttle 3.12 was as much as fourfold higher than that of the vpr / were made that led to changes in the coding for amino parental vector. This observation supports an early role acid 30 (alanine to phenylalanine; Vpr mutant A30F); this of vpr in the HIV-1 replication cycle. These data support residue is near the amino-terminal end of Vpr in the the conclusion that the vpr gene partially accounts for predicted a-helical region of the protein (residues 17-the lower than predicted in vivo mutation rate of HIV-1. 34). Mutagenesis of this domain has been found to affect Vpr stability and the efficiency of Vpr incorporation into MATERIALS AND METHODS virions (Mahalingam et al., 1995a,b,c) . This particular amino acid substitution mutation in the vpr gene has HIV-1 vectors and expression plasmids been previously reported to limit the incorporation of Vpr into virus particles (Yao et al., 1995) . The plasmid pHIV shuttle 3.12 ( Fig. 1) was constructed
The HIV-1 gag-pol expression plasmid used, pSVgagas described (Mansky and Temin, 1995) . A vpr 0 derivative of pHIV shuttle 3.12, pHIV shuttle 3.12 vpr ATG 0 , was pol-rre-r (Smith et al., 1990) , was kindly provided by David Rekosh, University of Virginia. The amphotropic murine mids and the HIV-1 tat expression plasmid (Step 2 cells); in complementation experiments, pCMVvpr was tranleukemia virus env expression plasmid used, pSV-A-MLV-env (Landau and Littman, 1992) , was provided by siently transfected along with these plasmids.
Step 2 clones were tested by Southern analysis to ensure that Dan Littman, University of California, San Francisco. The vpr expression plasmid, pCMVvpr, was constructed by only a single vector proviral DNA was present. The lacZa peptide gene in the vector proviral DNA of Step 2 clones amplifying the vpr gene from HIV shuttle 3.12 by PCR and inserting it into a eukaryotic expression vector that was sequenced to confirm that no mutations were introduced. In Step 3, vector virus was transferred to fresh contains the CMV promotor (pCR3; Invitrogen).
HeLa target cells by cocultivation 24-48 hr after transient Cells and media transfection of helper plasmids; cells were then placed under G418 selection (Step 3 cells). Cocultivation was The HeLa and COS-1 cell lines used were obtained used to produce
Step 3 cells to maximize the number of from the American Type Culture Collection (Rockville,
Step 3 cells for analysis of the mutation rate. MD) and were maintained in Temin's modified Eagle's medium (Temin, 1968) containing 10% calf serum or 10%
Recovery of shuttle vector proviral DNA and DNA fetal bovine serum, respectively.
sequencing of the lacZa peptide region Transfections, infections, and cocultivations Purified genomic DNA (Sambrook et al., 1989 ) from pools of Step 3 clones was digested with the restriction HIV-1 vectors and expression plasmids were transenzymes StuI and XhoI, to release the neo, pACYC origin fected into COS-1 or HeLa cells by use of DMSO/polyof replication, and lacZa peptide gene sequences from brene (Kawai and Nishizawa, 1984) . HeLa cells were the HIV-1 shuttle vector proviral DNA ( Fig. 1 ). Proviral infected in the presence of polybrene .
DNA was purified with the Lac repressor protein (ProInfection of HeLa target cells was done by cocultivation mega) as previously described (Mansky and Temin, of virus-producing cells with target cells . The purified proviral DNA was treated with the 1995; Mansky and Temin, 1994) . Briefly, virus-producing Klenow fragment of DNA polymerase to fill in singlecells (typically 2.5 1 10 5 cells per 60-mm petri dish, 5 1 stranded ends, and was ligated and used to electropor-10 5 cells per 100-mm petri dish, or 7.5 1 10 5 cells per ate competent Escherichia coli XLI Blue cells. Kanamy-150-mm petri dish) were treated with mitomycin C (10 cin-resistant bacterial colonies were selected in the mg/ml), an inhibitor of host cell DNA synthesis, for 2 hr presence of the 5-bromo-4-chloro-3-indolyl-b-D-thiogaat 37Њ. The cells were then washed three times with fresh lactopyranoside inducer. The ratio of white plus light-blue medium, and HeLa target cells equivalent to the number bacterial colonies to total bacterial colonies observed of treated virus-producing cells were added. Two days provided a forward mutation rate for a single retroviral after cocultivation, selective medium containing G418 replication cycle. Plasmid DNA was purified (Sambrook was added. Control experiments were done with each et al., 1989) and sequenced in the lacZa peptide gene cocultivation experiment to ensure that mitomycin Cregion with a nonradioactive DNA sequencing kit (Protreated, virus-producing cells did not proliferate and no mega Corp.) and by an automated DNA sequencer (Aplonger adhered to the surfaces of culture dishes. Cells plied Biosystems). expressing the neo gene were selected with the neomycin phosphotransferase analog, G418, until the formation Cell radiolabeling and immunoprecipitation analysis of colonies (typically about 3 weeks).
Step 2 cells with HIV shuttle 3.12 or derivatives with Strategy for generating a single cycle of retrovirus vpr mutations were metabolically labeled with [ 35 S]-replication methionine (100 mCi/ml) for approximately 15 hr after transfection with helper plasmids. Virus particles proThe experimental protocol developed to assay a single cycle of HIV-1 shuttle vector replication is shown in Fig. duced during the labeling were pelleted through a 20% sucrose cushion in a Beckman SW28 rotor for 90 min 2. The protocol contains three steps. In Step 1, the HIV-1 shuttle vector was introduced into COS-1 cells by transat 4Њ. Cells and pelleted virions were lysed in immunoprecipitation buffer (1% Triton X-100, 0.5% deoxychofection and placed under G418 selection. Cell clones were then transiently transfected with the helper plaslate, 0.1% sodium dodecyl sulfate, and 0.2 mM phenylmethylsulfonyl fluoride in phosphate-buffered saline) mids pSVgagpol-rre-r and pSV-A-MLV-env along with a HIV-1 tat expression plasmid, pSVtat (Kao et al., 1987;  and then immunoprecipitated with a rabbit anti-Vpr serum (deposited by L. Ratner in the AIDS Research and Peterlin et al., 1986) (to aid in expression of the accessory genes from the shuttle vector). In Step 2, vector virus Reference Reagent Program, National Institute of Allergy and Infectious Diseases, Bethesda, MD) abwas harvested 48 hr posttransfection from Step 1 cells and used to infect fresh HeLa cells. G418-resistant cell sorbed to protein A -agarose beads (Bethesda Research Laboratories, Gaithersburg, MD). clones were transiently transfected with the helper plas- Step 1, COS-1 cells were transfected with a pHIV shuttle 3.12 or a derivative and were placed under G418 selection. These cells were transiently transfected with the HIV-1 gag-pol expression plasmid, pSVGAGPOL-rre-r, the amphotropic murine leukemia virus env gene, pSV-A-MLV-env, and a HIV-1 tat expression plasmid, pSVtat (to aid in expression of the accessory genes from the shuttle vector). Fourty-eight hours posttransfection, virus was harvested and used to infect HeLa cells. G418-resistant cell clones were transiently transfected with pSVGAGPOL-rre-r, pSV-A-MLV-env, and the tat expression plasmid (Step 2 cells). Twenty-four to 48 hr posttransfection, Step 2 cells were treated with mitomycin C and cocultivated with fresh HeLa target cells, and all cells were placed under G418 selection (Step 3 cells). (B) One round of HIV-1 shuttle vector virus replication. The steps going from a parental shuttle vector provirus in the Step 2 cell to a vector provirus in the Step 3 cell constitute a single cycle of replication. These steps include transcription of the proviral DNA by the cellular transcription machinery, packaging of the viral RNA, release of viral particles, infection of target cells, reverse transcription, and integration of newly synthesized viral DNA to generate a vector provirus.
RESULTS
or 7.5 1 10 5 cells per 150-mm petri dish; mitomycin C is an inhibitor of host cell DNA synthesis and led to Replication of the HIV-1 shuttle vectors containing cell death of Step 2 cells as described under Materials mutations of the vpr gene and Methods) with fresh HeLa target cells to produce
Step 3 cells led to titers of 8 1 10 2 -3 1 10 3 CFU/2.5 1 The HIV-1 shuttle vectors used in these studies were 10 5 HeLa target cells. The steps going from a parental based on HIV shuttle vector 3.12 ( Fig. 1) , which contains shuttle vector provirus in the Step 2 cells to a vector a deletion in the gag-pol and env genes with an inserprovirus in the Step 3 cells constitute a single cycle tion, in the env gene, of a cassette containing the neo of replication (Fig. 2) . These steps include transcripgene, the pACYC origin of replication, and the lacZa tion of the proviral DNA by the cellular transcription peptide gene. These vectors replicate in mammalian machinery, packaging of the viral RNA, release of viral cells as a virus and can be selected with the neomycin particles, infection of target cells, reverse transcripanalog G418. The vectors can replicate in E. coli as a tion, and integration of newly synthesized viral DNA plasmid and are selected using the drug kanamycin. To to generate a vector provirus. Southern analysis of be packaged into a virus particle, these vectors are comtotal DNA from each Step 2 cell clone (after transient plemented in trans by transient transfection of cells with transfection with the helper plasmids) of HIV shuttle an HIV-1 gag-pol expression plasmid and an ampho-3.12 or derivatives was done to ensure that each cell tropic murine leukemia virus env expression plasmid.
clone used contained only one provirus copy (data not Vector virus produced from either COS-1 or HeLa shown). Proviral DNA from at least 5 1 10 5 cells of cells was used to infect fresh HeLa target cells (Fig.  each Step 2 cell clone was purified using the Lac 2). Cocultivation was used to produce Step 3 cells repressor protein and introduced into E. coli to screen because it was desirable to obtain the largest number for mutations in the lacZa gene region; blue colonies of Step 3 cells for analysis of the mutation rate. Coculwere observed for each
Step 2 clone (data not shown), tivation of mitomycin C-treated Step 2 cells of HIV indicating that the bacterial colonies containing vector shuttle 3.12 or derivatives (typically 2.5 1 10 5 cells per 60-mm petri dish, 5 1 10 5 cells per 100-mm petri dish, proviral DNA had the wild-type lacZa gene phenotype. to A transition mutations. These mutants are likely to have resulted from proviral DNA synthesis catalyzed by an error-prone reverse transcriptase. Since the forward The lacZa gene region in the vector proviral DNA of mutation rate of HIV-1 is 3 1 10 05 mutations per base each Step 2 clone was sequenced to confirm that no pair per cycle (Mansky and Temin, 1995) , the observation mutations had been introduced into the lacZa gene of 2 or more mutations in the 280-base lacZa peptide region in the steps leading to the vector provirus in gene region is indicative of hypermutation (Pathak and the Step 2 cell. The templates used for DNA sequenc- Temin, 1990a ). ing were from proviral DNA purified from Step 2 cells using the Lac repressor protein and proviral DNAs from at least three blue colonies (from the above pheEffect of a mutation that limits incorporation of Vpr into virus particles on the mutation rate notypic analysis in E. coli) for each Step 2 clone used; DNA sequencing indicated that each Step 2 clone con-A mutation in the vpr gene was made that would tained the wild-type lacZa gene sequence (data not limit incorporation of Vpr into virus particles, without shown). The vpr gene in the vector proviral DNA of the resulting in large structural changes to the protein. Speparental Step 2 clones was sequenced to confirm that cifically, a vpr mutant based on HIV shuttle 3.12 was no mutations had been introduced in the steps leading made that would express Vpr with a single amino acid to the vector provirus in the Step 2 cell (data not substitution at residue 30 (changing alanine to phenylshown).
alanine) in the a-helical domain located near the amino terminus of the protein; this mutant has been reported Mutation frequency, type, and location observed with to limit the incorporation of Vpr into virus particles (Yao a vpr 0 HIV-1 shuttle vector et al., 1995). Vector virus produced from COS-1 cells was used to infect fresh HeLa target cells.
Step 2 cells A HIV-1 shuttle vector containing a mutation of the vpr gene start codon was used (i.e., HIV shuttle 3.12 vpr containing this shuttle vector were transfected with the helper plasmids, and were cocultivated with fresh HeLa ATG 0 ). This vector was tested in parallel with the parental vector ( Table 1 ). The proviral DNA from pooled Step 3 target cells to produce Step 3 cells in parallel with cocultivation of fresh HeLa cells with the vpr / parental cells representing over 70,000 different cell clones of the vpr 0 mutant was purified with the Lac repressor protein shuttle vector. The proviral DNA from pooled Step 3 cells representand introduced into E. coli to screen for mutations in the lacZa gene region. Vector DNAs with mutations at target ing over 50,000 different cell clones was purified with the Lac repressor protein and introduced into E. coli to nucleotides, previously determined to lead to a phenotypic change (Bebenek et al., 1989; Pathak and Temin, screen for mutations in the lacZa gene region. Three thousand ninety-two bacterial colonies were screened 1990b), were detectable as bacterial colonies with a white or light-blue colony color phenotype. Three thoufor shuttle vector proviral DNAs containing mutations in the lacZa peptide gene (Table 2) . Fourty-four of these sand two hundred fifty-four bacterial colonies were FIG. 3 . Plus-strand nucleotide sequence of the lacZa gene region in a HIV shuttle 3.12 derivative containing a mutation of the vpr gene start codon. The start for nucleotide numbering is the beginning of the 5 long terminal repeat of HIV shuttle 3.12. The start and stop codons of the lacZa open reading frame (small boxed sequences) and the lac operator sequence (large boxed sequence) are shown. Nucleotide positions of base pair substitutions (letters above the sequence), /1 frameshifts (letters with ᭢ above the sequence), 01 frameshifts (᭞ above the sequence), and deletions (solid black lines with arrows above or below the sequence and adjacent to the deletion names) are indicated. Mutations from the same mutant are designated with a Greek letter adjacent to each mutation; identical Greek letters indicate mutations from the same mutant. The locations of base-substitution, frameshift, and deletion mutations in the parental vector, HIV shuttle vector 3.12, from parallel experiments (see Table  1 ) are indicated below the nucleotide sequence. colonies had a white or light-blue colony color phenoThese cells were then cocultivated with fresh HeLa target cells to produce Step 3 cells along with parallel cocultivatype. The mutation frequency was 44/3092 or 14 1 10 03 tion experiments using the vpr / parental vector. mutations per cycle. The mutation frequency of the vpr / The proviral DNA from pooled Step 3 cells representing parental vector in parallel experiments was 10/2450 or over 50,000 different cell clones was purified with the Lac 4 1 10 03 mutations per cycle. The mutation frequency of repressor protein and introduced into E. coli to screen for the shuttle vector containing the amino acid substitution mutations in the lacZa gene region. Two thousand nine in Vpr was significantly different from that obtained with hundred ninety-two bacterial colonies were screened for the parental vector (x 2 Å 14; P õ 0.01), but was not vpr-complemented shuttle vector proviral DNAs containing different than the mutation frequency of the vpr 0 vector mutations in the lacZa peptide gene (Table 3) . Nineteen (x 2 Å 0.14; P ú 0.1). These results indicate the requireof these colonies had a white or light-blue colony color ment of efficient Vpr incorporation in order to observe phenotype. The mutation frequency for the vpr-complethe influence of the vpr gene on the rate of mutation.
mented shuttle vector was 19/2992 or 6 1 10 03 mutations per cycle. The mutation frequency of the vpr / parental vecComplementation in trans of mutations in the vpr tor done in parallel experiments was 11/2074 or 5 1 10 03 gene mutations per cycle. The mutation frequency of the comple-HIV shuttle 3.12 vpr ATG 0 was used to test for complemented vector was not significantly different from the mutamentation in trans of the vpr mutations made in HIV shuttion frequency of the parental vector (x 2 Å 0.23; P ú 0.1), tle vector 3.12. Complementation was determined based but was significantly different from the mutation frequency on the mutation rate of the vector.
Step 2 cells containing of the vpr 0 vector (x 2 Å 11; P õ 0.01). This provides evi-HIV shuttle 3.12 vector vpr ATG 0 were transfected with dence that a vpr 0 vector can be complemented in trans with a vpr expression plasmid. the helper plasmids and the vpr expression plasmid. Vpr in cells transiently transfected with the helper plasmids and the tat expression plasmid (Fig. 4A, lane 2) . The relatively low expression of Vpr from HIV shuttle 3.12 Expression of Vpr from virus-producing cells in the untransfected
Step 2 cells provides an explanation The expression and virion-incorporation of Vpr with as to why these cells are able to proliferate in the pres-HIV shuttle 3.12 and derivatives used in this study was ence of the wild-type vpr gene. Vpr was detected in virianalyzed (Fig. 4) to confirm the correlation between Vpr ons only from the transiently transfected cells producing virion incorporation and the influence of the vpr gene on virus particles (Fig. 4B, lane 2) . In total, these data supthe mutation rate. Expression of Vpr in cells with the vpr 0 port the correlation between Vpr virion incorporation and mutant HIV shuttle 3.12 vpr ATG 0 was not detected in the influence of vpr on the mutation rate. cells (Fig. 4A, lane 3) or virus particles (Fig. 4B, lane 3) . Vpr was expressed with HIV shuttle 3.12 Vpr A30F in DISCUSSION cells (Fig. 4A, lanes 4) , but was not detected with virus
The HIV-1 accessory gene vpr was mutated to deterparticles (Fig. 4B, lanes 4) . In the trans-complementation mine whether the vpr gene could, at least in part, account experiment of HIV shuttle 3.12 vpr ATG 0 with a wild-type for the lower than predicted in vivo mutation rate of HIVvpr expression plasmid, Vpr was detected from cells (Fig. 1. Mutation of the vpr gene start codon was made and 4A, lane 5) and from virus particles (Fig. 4B, lane 5) .
introduced into a HIV-1 shuttle vector that has been used to determine the in vivo mutation rate of HIV-1 (Mansky   TABLE 3 and . The mutation rate of this vpr 0 vector was determined using the lacZa peptide gene as a re- compared to similar proportions of the parental vector localization of HIV-1 DNA in nondividing cells (Heinzinger et al., 1994) . (Gibbs et al., 1995 (Boyer et al., 1992; Mansky and Temin, 1995 lication accessory proteins that affect the accuracy of replication have been described for other viruses. For (Table 4) . However, the increase in the overall mutation example, bacteriophage T4 encodes two proteins, gene rate observed with the vpr 0 vectors coincided with a 32 protein (a helix-destabilizing protein) (Hurley et al. , similar increase in the rate of mutation of base-substitu-1993) and gene 45 protein, that are part of the replication tion and frameshift mutations and a fourfold increase complex and have been shown to influence the accuracy in the number of mutants containing multiple mutations of replication (Mufti, 1979 (Mufti, , 1980 Topal and Sinha, 1983 ; recovered to that of the parental vector. An increase in Watanabe and Goodman, 1978) . the number of multiple mutants along with the increase The imbalance of deoxynucleotide triphosphate pools in mutation rate indicates that the incidence and not the has been suggested to influence the efficiency and accuspecificity of mutations occurring during the single round racy of HIV-1 replication and the fidelity of purified HIVof HIV-1 replication was influenced by mutation of the 1 reverse transcriptase Martinez vpr gene. et al., 1994; Meyerhans et al., 1994; . The mechanism by which the vpr gene influences the A possible effect of the vpr gene on HIV-1 reverse tranmutation rate, as well as the function(s) of the vpr gene scription could be to influence the access of deoxyin the replication cycle of HIV-1, is not entirely clear; the nucleotide triphosphates to reverse transcriptase. influence of vpr on the mutation rate that was observed in this study could be either direct or indirect. However, our findings indicate that the vpr gene influences an early ACKNOWLEDGMENTS step in the replication cycle of HIV-1 (i.e., reverse transcription). (Levy et al., 1994 , to influence HIV-1 tranDawn Burns, Norman Drinkwater, Eric Freed, Tom Mitchell, Gary Pulsinelli, Bill Sugden, and Shiaolan Yang for helpful discussions; Vinay scription , to inhibit proliferation and tion (Rogel et al., 1995) , and to be involved in the nuclear
